<--- Back to Details
First PageDocument Content
Nitriles / Organofluorides / Prostate cancer / Ribbon symbolism / MDV3100 / Degarelix / Breast cancer / Erlotinib / Galeterone / Chemistry / Organic chemistry / Medicine
Date: 2014-10-30 05:54:55
Nitriles
Organofluorides
Prostate cancer
Ribbon symbolism
MDV3100
Degarelix
Breast cancer
Erlotinib
Galeterone
Chemistry
Organic chemistry
Medicine

R&D Pipeline (October[removed]Global Development (1) Approval / Labeling Revision #Compounds with "In-house" in this column include one discovered by collaborative research. (The same applicable hereafter.) Code No. Gen

Add to Reading List

Source URL: www.astellas.com

Download Document from Source Website

File Size: 100,19 KB

Share Document on Facebook

Similar Documents

Some people using buy iressa in canada this medication guide. So with that in mind when evaluating the desirability of including a drug of abuse and you won’t need to be bored. Food and Drug Administration. It helps ke

Some people using buy iressa in canada this medication guide. So with that in mind when evaluating the desirability of including a drug of abuse and you won’t need to be bored. Food and Drug Administration. It helps ke

DocID: 1r8zb - View Document

Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016

Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016

DocID: 1qPF6 - View Document

PRESS RELEASE  Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

DocID: 1qlMF - View Document

TECHNOLOGY OFFER  A COBALT-BASED STRATEGY FOR TUMOUR TARGETING OF EGFR-INHIBITORS BACKGROUND The development of receptor tyrosine-kinase inhibitors (TKIs) in recent

TECHNOLOGY OFFER A COBALT-BASED STRATEGY FOR TUMOUR TARGETING OF EGFR-INHIBITORS BACKGROUND The development of receptor tyrosine-kinase inhibitors (TKIs) in recent

DocID: 1pWe8 - View Document

erlotinib and 3a4 substrate, erlotinib cell lines fda erlotinib supllemental. erlotinib dialogo farmaci. erlotinib egfr erlotinib and gefitinib australia erlotinib lung asians. oral therapy erlotinib rash and erlotinib f

erlotinib and 3a4 substrate, erlotinib cell lines fda erlotinib supllemental. erlotinib dialogo farmaci. erlotinib egfr erlotinib and gefitinib australia erlotinib lung asians. oral therapy erlotinib rash and erlotinib f

DocID: 1pHKm - View Document